companydata.dkcompanydata.dk

EP MEDICAL ApS: Financial statements 2021

CVR: 29631905

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

EP MEDICAL ApS (CVR 29631905) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 300,363 and a net result of DKK 299,274 compared with DKK -101,252 the year before. That is a decrease of 18.6% compared with the year before. The profit margin was 99.6%. Equity in the 2021 report amounted to DKK 7,407,928. The solvency ratio was 98%. The company had 1 employee in the financial year.

Revenue
DKK 300,363
Gross Profit
DKK 174,975
Profit/Loss
DKK 299,274
Equity
DKK 7,407,928
Total Assets
DKK 7,556,021
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021300K175K299K7.4M1
2020369K268K-101K7.2M1
2019804K605K856K7.4M1
2018482K275K-667K6.7M1
2017438K194K-206K7.5M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like EP MEDICAL ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

EP MEDICAL ApS: The 2020 annual report is outFeb 22, 2021

EP MEDICAL ApS has published its annual report for 2020. Revenue came to DKK 369,060, and the net result was DKK -101,252.

About EP MEDICAL ApS

EP MEDICAL ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named EP MEDICAL CONSULTING ApS and REFLAB HOLDING ApS. The management consists of Eva Valbjørn Sørensen. The company is owned by Per Stahl Skov and Eva Valbjørn Sørensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 265,299 and a net result of DKK -348,750 compared with DKK 182,500 the year before. Equity in the 2025 report amounted to DKK 5,784,791.

Source: annual report 2025, Danish Business Authority